ROLE OF COMPUTATIONAL CHEMISTRY IN SUPPORT OF HAZARD IDENTIFICATION (ID) - MECHANISM-BASED SARS

被引:5
|
作者
RICHARD, AM
机构
[1] Health Effects Research Laboratory (MD-68) U.S. Environmental Protection Agency, Research Triangle Park
关键词
COMPUTATIONAL CHEMISTRY; MOLECULAR MODELING; MECHANISM-BASED STRUCTURE-ACTIVITY; SAR; HAZARD IDENTIFICATION;
D O I
10.1016/0378-4274(95)03363-P
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
A mechanism-based structure-activity relationship (SAR) study examines the structural basis for a chemical/biological activity by targeting a single or a few stages in a postulated mechanism of action. Computational chemistry approaches provide a valuable complement to experiment for probing such associations, but require a highly focused viewpoint that neglects much of the full biological and chemical interaction problem. Research questions are formulated in terms of fundamental structure and reactivity properties and are designed to test key assumptions of a postulated mechanism of activity. The results of such studies can aid in the generation of new hypotheses, suggest new experiments, and provide scientific rationale for extrapolation in hazard identification (ID). Toxicologists and computational chemists bring very different, yet complementary viewpoints, approaches: and expertise to bear on the hazard ID problem. However, improved communication and interaction between these two groups is needed to most productively address hazard ID issues.
引用
收藏
页码:115 / 122
页数:8
相关论文
共 50 条
  • [21] Tryptophan synthase mutations that alter cofactor chemistry lead to mechanism-based inactivation
    Jhee, KH
    McPhie, P
    Ro, HS
    Miles, EW
    BIOCHEMISTRY, 1998, 37 (41) : 14591 - 14604
  • [22] A mechanism-based approach to the identification of age-period-cohort models
    Winship, Christopher
    Harding, David J.
    SOCIOLOGICAL METHODS & RESEARCH, 2008, 36 (03) : 362 - 401
  • [23] Emerging systems biology approaches in nanotoxicology: Towards a mechanism-based understanding of nanomaterial hazard and risk
    Costa, Pedro M.
    Fadeel, Bengt
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 299 : 101 - 111
  • [24] Mechanism-based computational models to study interplay between EGFR inhibitors and KRAS mutants
    Stites, Edward C.
    CANCER RESEARCH, 2020, 80 (11) : 35 - 35
  • [25] Massive computational acceleration by using neural networks to emulate mechanism-based biological models
    Wang, Shangying
    Fan, Kai
    Luo, Nan
    Cao, Yangxiaolu
    Wu, Feilun
    Zhang, Carolyn
    Heller, Katherine A.
    You, Lingchong
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [26] Massive computational acceleration by using neural networks to emulate mechanism-based biological models
    Shangying Wang
    Kai Fan
    Nan Luo
    Yangxiaolu Cao
    Feilun Wu
    Carolyn Zhang
    Katherine A. Heller
    Lingchong You
    Nature Communications, 10
  • [27] A mechanism-based cross-linker for the identification of kinase-substrate pairs
    Maly, DJ
    Allen, JA
    Shokat, KM
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (30) : 9160 - 9161
  • [28] IDENTIFICATION AND CHARACTERIZATION OF ERLOTINIB AS A POTENT MECHANISM-BASED INACTIVATOR OF HUMAN ALDEHYDE OXIDASE
    Dick, Ryan A.
    Liang, Xiaomin
    Sun, Hailing
    Murray, Bernard P.
    Smith, Bill J.
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [29] Mechanism-based dual reporter screening system assists in identification of translational inhibitors
    Lukianov, D.
    Lisevich, I.
    Marina, V.
    Wieland, M.
    Maviza, T.
    Rasumova, E.
    Ferberg, A.
    Tochilkina, M.
    Ibitoye, O.
    Tashlitsky, V.
    Polshakov, V.
    Iarovenko, S.
    Komarova, K.
    Wilson, D.
    Sergiev, P.
    Dontsova, O.
    Osterman, I.
    FEBS OPEN BIO, 2021, 11 : 152 - 153
  • [30] A mechanism-based cross-linker for the identification of kinase-substrate pairs
    1600, American Chemical Society, Columbus, United States (126):